Axsome Therapeutics
AXSM
AXSM
408 hedge funds and large institutions have $6.41B invested in Axsome Therapeutics in 2026 Q1 according to their latest regulatory filings, with 71 funds opening new positions, 144 increasing their positions, 142 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.55% less ownership
Funds ownership: 74.66% → 74.11% (-0.55%)
7% less capital invested
Capital invested by funds: $6.86B → $6.41B (-$457M)
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Holders
408
Holding in Top 10
9
Calls
$140M
Puts
$110M
Top Buyers
| 1 | +$92.2M | |
| 2 | +$70.3M | |
| 3 | +$68.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$66.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$63.9M |
Top Sellers
| 1 | -$162M | |
| 2 | -$50.9M | |
| 3 | -$38.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$33.3M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$31M |
